Issued Patents All Time
Showing 1–25 of 26 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 6667058 | Oral forms of administration containing solid flupirtine with controlled release of active substance | Joachim Goede, Helmut Momberger, Jurgen Engel, Michael Lobisch | 2003-12-23 |
| 6348490 | Dosage forms containing thioctic acid or solid salts of thioctic acid with improved release and bioavailability | Matthias Rischer, Werner Sarlikiotis | 2002-02-19 |
| 6284787 | Use of R-(+)-.alpha.-lipoic acid, R-(-)-dihydrolipoic acid and metabolites in the form of the free acid or as salts or esters or amides for the preparation of drugs for the treatment of diabetes mellitus as well as of its sequelae | Klaus Wessel, Harald Borbe, Heinz Ulrich, Hans Bisswanger, Lester Packer +1 more | 2001-09-04 |
| 6271254 | Pharmaceutical compositions containing R-.alpha.-lipoic acid or S-.alpha.-lipoic acid as active ingredient | Heinz Ulrich, Carl-Heinrich Weischer, Jurgen Engel | 2001-08-07 |
| 6117899 | Use of R-(+)-.alpha.-lipoic acid, R-(-)-dihydrolipoic acid and metabolites in the form of the free acid or as salts or esters or amides for the preparation of drugs for the treatment of diabetes mellitus as well as its sequelae | Klaus Wessel, Harald Borbe, Heinz Ulrich, Hans Bisswanger, Lester Packer +1 more | 2000-09-12 |
| 6017909 | Salts of azelastine having improved solubility effective at treating psoriasis and providing a cytoprotective effect | Reinhard Muckenschnabel, Gerhard Scheffler, Ilona Fleischhauer, Wolfgang Morick | 2000-01-25 |
| 5998403 | Salts of azelastine having improved solubility useful at providing a cytoprotective effect | Reinhard Muckenschnabel, Gerhard Scheffler, Ilona Fleischhauer, Wolfgang Morick | 1999-12-07 |
| 5990152 | Dosage forms containing thioctic acid or solid salts of thioctic acid with improved release and bioavailability | Matthias Rischer, Werner Sarlikiotis | 1999-11-23 |
| 5948810 | Use of R-(+)-.alpha.-lipoic acid, R-(-)-dihydrolipoic acid and metabolites in the form of the free acid or as salts or esters or amides for the preparation of drugs for the treatment of diabetes mellitus as well as of its sequelae | Klaus Wessel, Harald Borbe, Heinz Ulrich, Hans Bisswanger, Lester Packer +1 more | 1999-09-07 |
| 5859003 | Salts of azelastine having improved solubility | Reinhard Muckenschnabel, Gerhard Scheffler, Ilona Fleischhauer, Wolfgang Morick | 1999-01-12 |
| 5728735 | Pharmaceutical composition containing R-.alpha.-lipoic acid or S-.alpha.-lipoic acid as active ingredient | Heinz Ulrich, Carl-Heinrich Weischer, Jurgen Engel | 1998-03-17 |
| 5693664 | Use of R-(+)-.alpha.-lipoic acid, R-(-)dihydrolipoic acid and metabolites in the form of the free acid or salts or esters or amides for the preparation of drugs for the treatment of diabetes mellitus as well as of its sequelae | Klaus Wessel, Harald Borbe, Heinz Ulrich, Hans Bisswanger, Lester Packer +1 more | 1997-12-02 |
| 5536444 | Compressed-gas packages using polyoxyethylene glyceryl fatty-acid esters as suspension stabilizers and valve lubricants | Reinhard Muckenschnabel | 1996-07-16 |
| 5527539 | Tablets with thioctic acid of specific particle size | Werner Sarlikiotis | 1996-06-18 |
| 5503845 | Tablets, granulates and pellets with a high active substance content for highly concentrated, solid dosage forms | Joachim Goede, Jurgen Engel | 1996-04-02 |
| 5415853 | Compressed gas packages using polyoxyethylene glyceryl oleates | Jurgen Engel, Reinhard Muckenschnabel | 1995-05-16 |
| 5376382 | Tablets, granulates and pellets with a high active substance content for highly concentrated, solid dosage forms of thioctic acid | Joachim Goede, Jurgen Engel | 1994-12-27 |
| 5271946 | Controlled release azelastine-containing pharmaceutical compositions | — | 1993-12-21 |
| 5164194 | Azelastine containing medicaments | — | 1992-11-17 |
| 5086050 | Method of treating inflammatory disorders and psoriasis with salts of azelastine | Reinhard Muckenschnabel, Gerhard Scheffler, Ilona Fleischhauer, Wolfgang Morick | 1992-02-04 |
| 5084481 | Method of treating inflammatory diseases with pharmaceutical composition containing dihydrolipoic acid as active substance | Heinz Ulrich, Carl-Heinrich Weischer, Jurgen Engel | 1992-01-28 |
| 5068233 | Synergistic combination of azelastine and theophylline or azelastine and .alpha.-mimetics | Ute Achterrath-Tuckerman, Rudolf Aurich, Jurgen Engel, Axel Kleeman | 1991-11-26 |
| 4812481 | Synergistic combination of amantadiene and selegiline | Dirk Reischig, Wolfgang Brade | 1989-03-14 |
| 4778799 | Synergistic combination of flupirtin and non-steroidal antiphlogistic | Ulrich Tibes, Carl-Heinrich Weischer, Hans-Peter Breuel | 1988-10-18 |
| 4673666 | 2-amino-3-ethoxycarbonylamino-6-(p-fluoro-benzylamino)-pyridine gluconate and pharmaceutical preparations containing it | Peter Emig, Jurgen Engel | 1987-06-16 |